Sujit Sheth
Chief, Pediatric Hematology/Oncology · Cornell Univ Joan and Sanford I Weill Med Coll
Credentials: · · ·
History
PresentPediatric Hematology/Oncology Division · Cornell Univ Joan and Sanford I Weill Med Coll
- Present
Comprehensive Thalassemia Program · Cornell Univ Joan and Sanford I Weill Med Coll
- 1991–1992
Pediatric Hematology-Oncology
- 1988–1991
Pediatrics
Research
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
New England Journal of Medicine · 2021 · 1,440 citations
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Cell · 2020 · 1,025 citations
Blood · 2010 · 408 citations
- GB
15 papers
9 papers
8 papers
8 papers
- SP
8 papers
7 papers
7 papers
6 papers
Grants
- 2019–2025
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.2M · Weill Medical Coll of Cornell Univ
- 2000–2006
Mentored Patient Oriented Hematology Research Training
National Heart, Lung, and Blood Institute · K23
Contact PI · $643.3K · Columbia University Health Sciences
- 2005–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $13.7K · Beth Israel Deaconess Medical Center
- 1998–2003
Comprehensive Sickle Cell Center of Manhattan
National Heart, Lung, and Blood Institute · P60
Project lead · $1M · Columbia University Health Sciences
Clinical trials
- 2020–2026
The BENeFiTS Trial in Beta Thalassemia Intermedia
Principal investigator · Enrolling by invitation · Phase 1, Phase 2
Phoenicia BioScience
- 2019–2025
Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy
Principal investigator · Completed
Weill Medical College of Cornell University
- 2013–2017
Safety and Efficacy of Eltrombopag at Escalated Doses
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University